Apotex, Impax lose appeal over AstraZeneca's Prilosec.
"This decision, upholding both the validity and enforceability of the patents, once again reaffirms the strength of our intellectual property," AstraZeneca spokesman Blair Hains said. Prilosec, which has the chemical name omeprazole, is sold without a prescription. AstraZeneca sells a newer version of the drug called Nexium and is fighting to keep copies of that medicine off the market as well. The case is In Re Omeprazole Patent Litigation, 2007-1414; 1416, 1458, and 1459 Court of Appeals for the Federal Circuit (Washington).
|Printer friendly Cite/link Email Feedback|
|Article Type:||Brief article|
|Date:||Sep 1, 2008|
|Previous Article:||Merck Vioxx trial was strategy to boost drug's sales.|
|Next Article:||Cell Genesys halts prostate-drug trial on higher deaths; shares plunge.|